Design of the Arizona CoVHORT: A Population-Based COVID-19 Cohort
Author
Catalfamo, C.J.Heslin, K.M.
Shilen, A.
Khan, S.M.
Hunsaker, J.R.
Austhof, E.
Barraza, L.
Cordova-Marks, F.M.
Farland, L.V.
Garcia-Filion, P.
Hoskinson, J.
Jehn, M.
Kohler, L.N.
Lutrick, K.
Harris, R.B.
Chen, Z.
Klimentidis, Y.C.
Bell, M.L.
Ernst, K.C.
Jacobs, E.T.
Pogreba-Brown, K.
Affiliation
Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, The University of ArizonaUniversity of Arizona Cancer Center
Department of Biomedical Informatics, College of Medicine–Phoenix, The University of Arizona
Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, The University of Arizona
Issue Date
2021
Metadata
Show full item recordPublisher
Frontiers Media S.A.Citation
Catalfamo, C. J., Heslin, K. M., Shilen, A., Khan, S. M., Hunsaker, J. R., Austhof, E., ... & Pogreba-Brown, K. (2021). Design of the Arizona CoVHORT: A Population-Based COVID-19 Cohort. Frontiers in Public Health, 9, 21.Journal
Frontiers in Public HealthRights
Copyright © 2021 Catalfamo, Heslin, Shilen, Khan, Hunsaker, Austhof, Barraza, Cordova-Marks, Farland, Garcia-Filion, Hoskinson, Jehn, Kohler, Lutrick, Harris, Chen, Klimentidis, Bell, Ernst, Jacobs and Pogreba-Brown. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
This study is a prospective, population-based cohort of individuals with a history of SARS-CoV-2 infection and those without past infection through multiple recruitment sources. The main study goal is to track health status over time, within the diverse populations of Arizona and to identify the long-term consequences of COVID-19 on health and well-being. A total of 2,881 study participants (16.2% with a confirmed SARS-CoV-2 infection) have been enrolled as of December 22, 2020, with a target enrollment of 10,000 participants and a planned follow-up of at least 2 years. This manuscript describes a scalable study design that utilizes a wide range of recruitment sources, leveraging electronic data collection to capture and link longitudinal participant data on the current and emerging issues associated with the COVID-19 pandemic. The cohort is built within a collaborative infrastructure that includes new and established partnerships with multiple stakeholders, including the state's public universities, local health departments, tribes, and tribal organizations. Challenges remain for ensuring recruitment of diverse participants and participant retention, although the electronic data management system and timing of participant contact can help to mitigate these problems. © Copyright © 2021 Catalfamo, Heslin, Shilen, Khan, Hunsaker, Austhof, Barraza, Cordova-Marks, Farland, Garcia-Filion, Hoskinson, Jehn, Kohler, Lutrick, Harris, Chen, Klimentidis, Bell, Ernst, Jacobs and Pogreba-Brown.Note
Open access journalISSN
2296-2565PubMed ID
33643990Version
Final published versionae974a485f413a2113503eed53cd6c53
10.3389/fpubh.2021.620060
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2021 Catalfamo, Heslin, Shilen, Khan, Hunsaker, Austhof, Barraza, Cordova-Marks, Farland, Garcia-Filion, Hoskinson, Jehn, Kohler, Lutrick, Harris, Chen, Klimentidis, Bell, Ernst, Jacobs and Pogreba-Brown. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
Related articles
- A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
- Authors: García IG, Rodriguez-Rubio M, Mariblanca AR, de Soto LM, García LD, Villatoro JM, Parada JQ, Meseguer ES, Rosales MJ, González J, Arribas JR, Carcas AJ, de la Oliva P, Borobia AM
- Issue date: 2020 Jun 3
- Concordance between self-reported SARS-CoV-2 positivity and laboratory-confirmed positivity.
- Authors: Catalfamo CJ, Jacobs ET, Falk LP, Lauro P, Ernst KC, Farland LV, Heslin KM, Pogreba-Brown K, Garcia-Filion PC
- Issue date: 2025
- Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
- Authors: Boon SS, Wong MCS, Ng RWY, Leung DTM, Chen Z, Lai CKC, Ho WCS, Huang J, Wong BKC, Fung KSC, Chan PKS
- Issue date: 2021 Nov 1
- Determining the incidence, risk factors and biological drivers of irritable bowel syndrome (IBS) as part of the constellation of postacute sequelae of SARS-CoV-2 infection (PASC) outcomes in the Arizona CoVHORT-GI: a longitudinal cohort study.
- Authors: Pogreba Brown K, Austhof E, McFadden CM, Scranton C, Sun X, Vujkovic-Cviji I, Rodriguez D, Falk L, Heslin KM, Arani G, Obergh V, Bessey K, Cooper K
- Issue date: 2025 Jan 30
- Elucidating symptoms of COVID-19 illness in the Arizona CoVHORT: a longitudinal cohort study.
- Authors: Khan SM, Farland LV, Catalfamo CJ, Austhof E, Bell ML, Chen Z, Cordova-Marks F, Ernst KC, Garcia-Filion P, Heslin KM, Hoskinson J, Jehn ML, Joseph ECS, Kelley CP, Klimentidis Y, Russo Carroll S, Kohler LN, Pogreba-Brown K, Jacobs ET
- Issue date: 2022 Jan 17

